Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Währung
EUR
Schneller Kontakt
Bitte senden Sie mir mehr Informationen über
Liraglutide Standard
Chemischer Name: H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(gamma-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH // Synonyme: N26-(Hexadecanoyl-gamma-glutamyl)-(34-arginine)GLP-1-(7-37), Lys(gamma-Glu-palmitoyl)26,Arg34)-GLP-1 (7-37), ), One letter Code:HAEGTFTSDVSSYLEGQAAK(gamma-Glu-palmitoyl)EFIAWLVRGRG
- Art-Nr.:LS-4051
- CAS Nr.:204656-20-2
- Formel:C172H265N43O51
- Molare Masse:3751,26 g/mol
- Reinheit:min. 99.0%, no single impurity
Startet von auf Anfrage
description
20mg per vial net peptide content, as peptide standard for quantitative analysis. Glucagon-Like-Peptide-1 (GLP-1) agonist used for the treatment of type 2 diabetes. It is an incretin mimetic stimulating the release and synthesis of insulin into the blood by the intestine in response to food. It is only active in the presence of high circulating glucose levels. It also slows the passage of food through the gut and reduces appetite.
references
Innovative chemical synthesis and conformational hints on the lipopeptide liraglutide; I. Guryanov, A. Bondesan, D. Visentini, A. Orlandin, B. Biondi, C. Toniolo, F. Formaggio, A. Ricci, J. Zanon and W. Cabri; J Pept Sci 2016; 22: 471-9. https://doi.org/10.1002/psc.2890
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide; J. Lau, P. Bloch, L. Schäffer, I. Pettersson, J. Spetzler, J. Kofoed, K. Madsen, L. B. Knudsen, J. McGuire, D. B. Steensgaard, H. M. Strauss, D. X. Gram, S. M. Knudsen, F. S. Nielsen, P. Thygesen, S. Reedtz-Runge and T. Kruse; Journal of medicinal chemistry 2015; 58: 7370-7380. https://doi.org/10.1021/acs.jmedchem.5b00726
The human GLP-1 analogs liraglutide and semaglutide: absence of histopathological effects on the pancreas in nonhuman primates; C. F. Gotfredsen, A. M. Molck, I. Thorup, N. C. Nyborg, Z. Salanti, L. B. Knudsen and M. O. Larsen; Diabetes 2014; 63: 2486-97. https://doi.org/10.2337/db13-1087
Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors; J. J. Neumiller; J Am Pharm Assoc (2003) 2009; 49 Suppl 1: S16-29. https://doi.org/10.1331/JAPhA.2009.09078
Liraglutide in type 2 diabetes: from pharmacological development to clinical practice; M. C. Rossi and A. Nicolucci; Acta Biomed 2009; 80: 93-101.
Potential of liraglutide in the treatment of patients with type 2 diabetes; C. F. Deacon; Vasc Health Risk Manag 2009; 5: 199-211. https://doi.org/10.2147/vhrm.s4039
Bulk oder Großmengen-Bestellung?
Sie benötigen größere Mengen für Ihre Entwicklung oder Produktion?
Benötigen Sie weitere Informationen über dieses Produkt?
kontaktieren Sie uns
Verwandte Produkte
![Structure image for E[c(RGDfK)]c(RGDfK)](https://www.iris-biotech.de/media/catalog/product/L/S/LS-3980.svg?width=240&height=140&store=de&image-type=small_image)
![Structure image for ICG-E[c(RGDfK)]2](https://www.iris-biotech.de/media/catalog/product/L/S/LS-3950.svg?width=240&height=140&store=de&image-type=small_image)
![Structure image for cyclo-[RGDfK(TPP)]](https://www.iris-biotech.de/media/catalog/product/L/S/LS-3920.svg?width=240&height=140&store=de&image-type=small_image)
Related news
-
News Amino Acids Building Blocks Product FocusPeptide Blockbusters Liraglutide and Semaglutide
Details ansehen
Produkte, die Sie auch interessieren könnten!
![Structure image for cyclo-[RGDfK(TPP)]](https://www.iris-biotech.de/media/catalog/product/L/S/LS-3920.svg?width=216&height=140&store=de&image-type=small_image)
